Clinical performance is complex and often involves multi-systematic stress. Early identification and standardized clinical care are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
Platforms can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Individualised development of treatment plans for treatment and management of thromboembolism is often required, including drug therapy, rehabilitation interventions, and regular follow-up dimension management. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many formerly difficult-to-treat diseases of the nervous system have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of stroke. The platform serves China International Medical Service System, a team of nationally and abroad authoritative experts in the field of neural systems, who provide the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.